Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy is a research paper published in Cancer Cell (2024). On theSindex it has a DataRank of 0. It has been cited 100 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: NS120060
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: F31 AR083279
National Science Foundation
Grant: 594598
National Science Foundation
Grant: DMS1763272
Melanoma Research Alliance
Grant: 929155
NIH
Grant: T32 AR080622
NIH
Grant: R01AI168063
NIH
Grant: U01AI160397
NIH
Grant: T32 AI177324
US Department of Defense
Grant: ME220176P1
NIAID NIH HHS
Grant: R01 AI163223
NCI NIH HHS
Grant: P30 CA062203
NCI NIH HHS
Grant: R01 CA278212
NINDS NIH HHS
Grant: R01 NS120060
NCI NIH HHS
Grant: P01 CA240239
NIAMS NIH HHS
Grant: P30 AR075047
NIAID NIH HHS
Grant: R01 AI123349
Adelson Family Foundation
University of California, Irvine
Chao Family Comprehensive Cancer Center
NSF
National Science Foundation Graduate Research Fellowship Program
Simons Foundation
Dr Miriam and Sheldon G Adelson Medical Research Foundation
Heising-Simons Foundation
MeSH Terms
Keywords